Organon (OGN) Cash from Investing Activities (2020 - 2026)

Organon (OGN) has reported Cash from Investing Activities for 7 consecutive years, with $386.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 324.42% year-over-year to $386.0 million; the TTM figure through Mar 2026 stood at $168.0 million (up 128.52% YoY), while the FY2025 annual figure was -$390.0 million, up 23.98% from the prior year.
• Cash from Investing Activities came in at $386.0 million for Q1 2026 at Organon, up from -$65.0 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $386.0 million in Q1 2026, with the low at -$296.0 million in Q4 2024.
• Average Cash from Investing Activities over 5 years is -$70.4 million, with a median of -$70.0 million recorded in 2023.
• Across the five-year window, Cash from Investing Activities sank 265.43% in 2024 and soared 324.42% in 2026, its largest moves.
• Year by year, Cash from Investing Activities stood at -$61.0 million in 2022, then tumbled by 32.79% to -$81.0 million in 2023, then tumbled by 265.43% to -$296.0 million in 2024, then soared by 78.04% to -$65.0 million in 2025, then soared by 693.85% to $386.0 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $386.0 million, -$65.0 million, and -$115.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.